Nov 2 (Reuters) - Insurance Australia Group Ltd (IAG) :
- RECEIVED ABOUT 14,000 CLAIMS BY 4PM ON 1 NOVEMBER AND THIS IS EXPECTED TO RISE FURTHER OVER COMING DAYS
- INCREASED ITS EXPECTATION FOR FY22 NET NATURAL PERILS CLAIM COSTS TO A$1,045 MILLION
- REVISED FY22 EXPECTATION ALSO INCLUDES APPROXIMATELY A$510 MILLION FOR PERILS EVENTS FOR REMAINDER OF FINANCIAL YEAR
- NET COST FOR EVENT ANTICIPATED TO BE A$169 MILLION, MAX RETENTION FOR FIRST LOSS UNDER IAG'S CATASTROPHE PROGRAM
- LOWERED ITS FY22 REPORTED INSURANCE MARGIN GUIDANCE RANGE FROM 13.5 - 15.5% TO 10.0 - 12.0%
- ESTIMATES THAT A$270 MILLION DEDUCTIBLE ATTACHED TO FY22 AGGREGATE COVER HAS BEEN ERODED BY A$209 MILLION AS A RESULT OF RECENT WEATHER EVENTS
- REMAIN CONFIDENT IN IAG'S OPERATIONAL MOMENTUM IN FY22, AFTER STRONG START IN Q1
- A$280 MILLION INCREASE IN NET NATURAL PERILS CLAIM COSTS EQUATES TO ABOUT 360 BASIS POINTS AT REPORTED INSURANCE MARGIN LEVEL
- Forums
- ASX - By Stock
- News: IAG IAG Increases Expectation For FY22 Net Natural Perils Claim Costs To A$1,045 Mln
IAG
insurance australia group limited
Add to My Watchlist
3.85%
!
$8.75

Nov 2 (Reuters) - Insurance Australia Group Ltd (IAG) :...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.75 |
Change
-0.350(3.85%) |
Mkt cap ! $20.69B |
Open | High | Low | Value | Volume |
$9.02 | $9.02 | $8.75 | $70.64M | 8.017M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 700 | $8.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.80 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 8.740 |
1 | 8 | 8.730 |
2 | 600 | 8.700 |
1 | 983 | 8.670 |
1 | 2 | 8.640 |
Price($) | Vol. | No. |
---|---|---|
8.800 | 2000 | 1 |
8.810 | 22117 | 3 |
8.820 | 2626 | 2 |
8.840 | 35138 | 1 |
8.890 | 566 | 1 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
IAG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online